← Back to Clinical Trials
Recruiting NCT07114744

NCT07114744 Early Cochlear Implant Use

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07114744
Status Recruiting
Phase
Sponsor NYU Langone Health
Condition Cochlear Implant Users
Study Type OBSERVATIONAL
Enrollment 25 participants
Start Date 2025-06-11
Primary Completion 2027-05-01

Trial Parameters

Condition Cochlear Implant Users
Sponsor NYU Langone Health
Study Type OBSERVATIONAL
Phase N/A
Enrollment 25
Sex ALL
Min Age 18 Years
Max Age 85 Years
Start Date 2025-06-11
Completion 2027-05-01
Interventions
Take home tests

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This observational study will examine newly activated cochlear implant users and determine whether their abilities to discern simple sounds change and relate to improved speech perception. Take-home computers and test-equipment will be sent home, and subjects will complete approximately 25 test sessions over the first 3 months of cochlea implant use. Then, subjects will be tested 3 more times in the laboratory until 1 year-post activation. The primary objective is to determine and quantify how sounds change and speech perception improves over the course of early cochlear implant use.

Eligibility Criteria

Inclusion Criteria: 1. Postlingually deaf cochlear implant users 2. severe or profound hearing loss 3. who do not have other diagnoses communicative or cognitive disorders. 4. Test population: no prior experience with cochlear implants (recruitment happens prior to cochlear implantation). 5. Control population: subjects who have used the same stimulation strategy since initial stimulation, who note no continuing improvements or changes with their devices with respect to speech comprehension. Exclusion Criteria: 1. Diagnosed cognitive or communicative disorders (other than deafness) 2. Below 18 years of age 3. Above the age of 85 years old.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology